RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Brazil: Meeting to Discuss New Criteria for Therapeutic Indications

Brazil: Meeting to Discuss New Criteria for Therapeutic Indications

Posted 11 June 2012 | By Ansis Helmanis

The Board of Anvisa, the national regulatory authority of Brazil, is scheduled to review new regulations governing the format of "non-print" instructions for use of health products and the criteria for a therapeutic indication at its next public meeting.

The Board will also receive a report by the Chief Executive Officer of Anvisa, Dirceu Barbano, on the international meeting of national regulators held in Geneva on 18 May that was organized by the agency on the topic of improving international regulatory cooperation.

Barbano will also report on the bilateral agreement signed in Germany between Anvisa and the Institute of Toxicological Evaluation of Germany.

The meeting will be held 14 June 2012.

Read more:

Anvisa - Anvisa announces agenda for the next public meeting of the Board

More Breaking News from RegLink


© 2022 Regulatory Affairs Professionals Society.